Master Protocol Guidance in Cancer R&D: Impact on IndustryByJeffrey HodgeJune 14th 2019FDA draft guidance for modernizing the approach to clinical trial design for oncology drugs and biologics look to make clinical trials more efficient while maintaining patient safety.